Your browser doesn't support javascript.
loading
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).
Saji, Shigehira; Ohsumi, Shozo; Ito, Mitsuya; Hayashi, Naoki; Kobayashi, Kokoro; Masuda, Norikazu; Niikura, Naoki; Yamashita, Toshinari; Kiyama, Keiichiro; Hasegawa, Ayumi; Nakagawa, Shizuka; Hattori, Masaya.
Afiliación
  • Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
  • Ohsumi S; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
  • Ito M; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Hayashi N; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan.
  • Kobayashi K; Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Masuda N; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Niikura N; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Kanagawa, Japan.
  • Yamashita T; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Kiyama K; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Hasegawa A; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Nakagawa S; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Hattori M; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
Jpn J Clin Oncol ; 52(10): 1124-1133, 2022 Oct 06.
Article en En | MEDLINE | ID: mdl-35750038
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article